Back to search

University of Patras

Η σκλήρυνση κατά πλάκας στην περιοχή της δυτικής Ελλάδας: επιδημιολογία της νόσου και κλινική μελέτη των πασχόντων

Abstract

dc:description

From our 23 year study on MS useful clinical and demographical data were obtained. After careful observation of our data from the Neurological clinic (beginning in 1983 from Agios Andreas General Hospital) we found 1651 cases with possible or definite MS. Of these, 834 eventually had definite MS. From the total 834 patients included in the study, the course of disease was not specified in 12 patients, as they lacked follow up data, although they had the diagnosis of definite MS. For the remaining 822 the course of disease was remitting-relapsing in 61.7%, secondary progressive in 22.1% and primary progressive in 16.2%. According to the Kurtzke functional systems incorporated in the Expanded Disability Status Scale (EDSS) many of our patients had more than one manifestation at onset. Specifically, 19.5% had multiple Kurtzke functional systems involved, while 80.5% had their initial clinical manifestation in only one functional system. Sensory symptoms were observed in 33.2% of our patients, pyramidal symptoms in 22.3% and symptoms of the visual system in 27.0%. The remaining patients were suffering from signs of the cerebellar system (5.1%), symptoms of the urogenital system (3.5%), brainstem system (3.8%) and symptoms related to mental and other functions e.g., seizures and non specific pain. The mean score for the Kurtzke Expanded Disability Status Scale (EDSS) was 2.88 (SD=1.8), range (0-9.5), with males showing significantly higher disability compared to females (Z =-3.138, p<.001). The mean age of the total sample of MS patients was 38.04 years, (SD=12.34) and the age range (15-75 years). Mean age of females was 36.61 years, (SD=12.40) and for males 40.08 years, (SD=11.96). The mean age at onset of the first symptom for males was 32.97 years, (SD=11.85) range (9-66 years), and 30.29 years, (SD=10.16) for females, range (9-68). A dependent samples t-test indicated a significant difference between the mean age at onset between males and females [t (348)=2.451, p=.015], with females showing earlier age at onset of first symptoms. As a group the mean age at onset was 31.41 years, (SD=10.97), a finding that is congruent with international data (mean age of disease onset between 20-40 years old). The mean duration of illness, from onset of disease until diagnosis was 2.62 years, (SD=5.26) range (0-40 years). We calculated mean annual incidence rate of definite MS for the period 1984-2006, which increased from 2.71 for the period 1984-1989 to 8.44/100,000 in 2002-2006 for males. For females we had increases from 2, 70/100.000 to 13,26/100.000. The total increase in incidence was from 2.71 to 10.73/100,000 population. We found a prevalence rate of 119.61/100,000 population and an increase in the mean annual incidence rate from 2.71 for the period 1984-1989 to 10.73/100,000 in 2002-2006. The highest prevalence rate was in the 35-54 age range, with a peak in the 45-54 range. Women also generally had higher rates than men. These figures place western Greece in the high risk area (and agree with the international literature) and are higher than reported previously in Greece but close to those reported recently in Southern Italy, Caltanissetta 165.8/100.00¹⁸⁵, and Catania 92.0/100,000¹⁸⁶, northwestern Italy, Genoa 94.0/100,000¹⁸⁷, Turkey, Istanbul 101.4/100.000¹⁸⁸, and Spain, Canary islands 77.5/100,000¹⁸⁹ population. The prevalence of MS in Greece rose significantly from 10.1/100.000 as recorded in 1984, 29.5 /100,000¹⁸⁰ in 1990, in northern Greece and 38.9/100,000¹⁸¹ in Evros, on December 31, 1999 to 119.61/100,000¹⁷⁷ population on December 31, 2006 in western Greece. The crude annual incidence rate increased from 2.11/100,000 in 1984 to 8.77/100,000 population in 2006. In the beginning of 1990, incidence rates were relatively low, gradually increasing from 1994 onwards, and eventually reaching a peak 14.85/100,000 population in 2004. The rates reported in this study are among the highest in Europe, and confirm Rosati¹⁹⁰ in that the substantially lower prevalence rates noted in previous surveys in Greece, do not actually reflect the true frequency of MS in the country. Factors that influenced our findings include: - The decreasing delay in the time between symptom onset and diagnosis of MS noted in the study clearly reflects the contribution of the most recently proposed diagnostic criteria of McDonald for MS, which rely heavily on the use of MRI findings. - With formal alterations in diagnostic criteria as applied in the study, increased awareness of MS due to easier availability and access to MRI and CSF analysis, in addition to increased awareness of MS therapies, the proportion of minimally affected individuals diagnosed with MS appears to be increasing substantially in western Greece. - Furthermore, the inclusion of only definite cases in serial prevalence studies like this survey, provide the most reliable and comparable estimate of MS frequency. - Easier diagnosis of MS from neurologists and changes in diagnostic criteria probably affected the incidence and prevalence rates noted in this study. Although these findings support the role of exogenous factors towards the acquisition of MS during the studied period, interactions between genetic background and environmental factors are noted as a possible cause of MS. Future studies are however needed in order to further examine epidemiological issues in Western Greece and the possible predisposing variables (genetic, viral, environmental or combination of these) towards MS acquisition. This will result in better health-care for these patients including their motor, emotional, cognitive and socioeconomic needs and the under covering of the mechanism of pathogenesis for the disease process, leading to better therapeutic and possibly preventive strategies.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Gourzoulidou, Efthymia
  • Γουρζουλίδου, Ευθυμία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/25739

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gourzoulidou, Efthymia; Γουρζουλίδου, Ευθυμία. Η σκλήρυνση κατά πλάκας στην περιοχή της δυτικής Ελλάδας: επιδημιολογία της νόσου και κλινική μελέτη των πασχόντων. University of Patras, 2008. http://hdl.handle.net/10442/hedi/25739